Table 7.
Liver function test in HCV infected and co-infected patients (mean ± SD, n = 29)
| Category |
Liver function test |
|||||||
|
Bilirubin (mg%) |
SAP (KA units) | ALT (IU/L) | AST (IU/L) | GGT (IU/L) | Albumin (gms%) | |||
| Total | Direct | Indirect | ||||||
| Control | 0.5340 ± 0.219 | 0.210 ± 0.055 | 0.386 ± 0.015 | 73.227 ± 21.622 | 37.76 ± 9.35 | 24.77 ± 07.65 | 69.70 ± 11.03 | 2.78 ± 0.219 |
| HCV positive patients | 3.461 ± 0.874 | 0.643 ± 0.1736 | 0.936 ± 0.016 | 144.630 ± 12.976 | 42.1 ± 8.3 | 49.00 ± 10.1 | 98.446 ± 09.57 | 3.87 ± 0.24 |
| P value | 0 | 0 | 0 | 0.005 | 0 | 0 | 0 | 0 |
| HCV and HBV coinfected patients | 3.70 ± 0.96 | 1.59 ± 0.06 | 1.641 ± 0.052 | 140.887 ± 10.922 | 58.0 ± 03.16 | 40.412 ± 02.008 | 99.362 ± 06.150 | 3.14 ± 0.66 |
| P value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| HCV and HIV coinfected patients | 2.920 ± 1.032 | 1.975 ± 0.941 | 1.997 ± 0.078 | 134.53 ± 10.651 | 56.78 ± 4.401 | 39.65 ± 2.24 | 97.60 ± 5.94 | 3.12 ± 0.97 |
| P value | 0 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0 | 0 |
| HCV, HBV and HIV coinfected patients | 3.295 ± 1.424 | 3.202 ± 0.488 | 0.265 ± 0.052 | 141 ± 17.301 | 64.37 ± 4.01 | 42.87 ± 2.84 | 99.95 ± 03.039 | 3.14 ± 0.02 |
| P value | 0.009 | 0 | 0 | 0 | 0.005 | 0.006 | 0.003 | 0.004 |
HCV positive patients: P values are based on students t test; P < 0.05 significant.